As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Abstract: This paper introduces a novel method for estimating the path loss value in indoor scenarios. It uses a combination of electromagnetic calculation and machine learning. Using electromagnetic ...